Azitra, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AZTR NYSE American 2836 azitrainc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Azitra, Inc.

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome - Jun 17th, 2025 6:02 am
Azitra, Inc. Announces Presentation at the 2025 BIO International Convention - Jun 10th, 2025 6:33 am
Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash - May 28th, 2025 6:33 am
AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025 - May 21st, 2025 4:16 am
Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash - May 14th, 2025 2:05 pm
Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates - May 13th, 2025 3:06 pm
Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025 - Apr 25th, 2025 6:33 am
Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline - Apr 24th, 2025 2:05 pm
Azitra to Present at Microbiome Times Partnering Forum - Mar 12th, 2025 6:33 am
AZTR: Netherton Topline Expected by Year-End - Mar 3rd, 2025 2:39 am
Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates - Feb 24th, 2025 6:30 am
Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock - Feb 4th, 2025 12:20 pm
Azitra, Inc. to Present at the BIO CEO & Investor Conference - Feb 3rd, 2025 7:05 am
Azitra, Inc. to Present at The Microcap Conference - Jan 27th, 2025 2:05 pm
Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock - Jan 15th, 2025 6:30 am
Azitra Announces Proposed Public Offering of Common Stock - Jan 14th, 2025 2:05 pm
AZTR: Planning 2nd Site for ATR-12 Trial - Nov 15th, 2024 8:14 am
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates - Nov 12th, 2024 3:05 pm
Azitra to Present at BIO-Europe 2024 - Oct 29th, 2024 7:00 am
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit - Oct 11th, 2024 7:00 am